Is Axon Enterprise (AXON) Fairly Priced After Sharp Pullback And Recent Rebound?
Axovant Sciences Ltd AXON | 0.00 |
- Wondering if Axon Enterprise at around US$403.54 is offering value or just a rich price tag at this point? This article walks through the numbers so you can judge how the stock stacks up against its fundamentals.
- The stock has gained 2.5% over the past week and 16.7% over the past month, yet it is still down 28.4% year to date and 41.8% over the last year, after a very large 5 year return of about 3x. That mix of recent strength and longer term drawdown can change how you think about both risk and opportunity.
- Recent coverage has focused on how Axon Enterprise's long term share price performance contrasts with its more recent pullback, which has prompted questions about whether sentiment has shifted too far. Other news has highlighted the company's role in public safety technology and ongoing product adoption, which some investors see as part of the context behind the stock's strong multi year return.
- On Simply Wall St's valuation checks, Axon Enterprise currently scores 1 out of 6 for being undervalued. The next sections will walk through what that means across different valuation methods and then finish with a broader way to think about the stock's value beyond the headline metrics.
Axon Enterprise scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.
Approach 1: Axon Enterprise Discounted Cash Flow (DCF) Analysis
A Discounted Cash Flow, or DCF, model projects a company’s future cash flows and then discounts those back to today’s value to estimate what the stock might be worth now.
For Axon Enterprise, Simply Wall St uses a 2 Stage Free Cash Flow to Equity model based on cash flow projections. The latest twelve month free cash flow is about $28.7 million. Analysts provide explicit forecasts out to 2028, where free cash flow is projected at $1.0b, and further years are extrapolated by Simply Wall St, with discounted values for each year out to 2035.
Bringing all those projected cash flows back to today results in an estimated intrinsic value of about $392.56 per share. Compared with a recent share price of around $403.54, the DCF output suggests Axon Enterprise trades at roughly a 2.8% premium to this intrinsic estimate, which is a relatively small gap in either direction.
Result: ABOUT RIGHT
Axon Enterprise is fairly valued according to our Discounted Cash Flow (DCF), but this can change at a moment's notice. Track the value in your watchlist or portfolio and be alerted on when to act.
Approach 2: Axon Enterprise Price vs Sales
For profitable companies that are still heavily reinvesting, the P/S ratio is often a useful cross check because it compares what the market is paying for each dollar of revenue, rather than focusing only on current earnings.
Growth expectations and risk matter here, because faster and more predictable revenue growth usually justifies a higher “normal” P/S multiple, while slower or less certain growth can point to a lower one. At around 10.90x, Axon Enterprise’s current P/S is higher than the Aerospace & Defense industry average of about 5.27x and above the peer average of roughly 7.89x.
Simply Wall St’s Fair Ratio for Axon Enterprise is 14.46x. This is a proprietary estimate of what P/S might be appropriate after adjusting for factors like revenue growth, profitability, industry, company size and risk. It is therefore more tailored than a simple comparison with peers or the broader industry, which may not share the same growth profile or risk characteristics. With the current P/S of 10.90x sitting below the Fair Ratio of 14.46x, this framework points to the stock trading at a discount on a sales multiple basis.
Result: UNDERVALUED
P/S ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.
Upgrade Your Decision Making: Choose your Axon Enterprise Narrative
Earlier it was mentioned that there is an even better way to understand valuation. Think of a Narrative as your clear story for Axon Enterprise that ties together what the company is doing, what you expect for its future revenue, earnings and margins, and what you see as a fair value, then compares that to today’s price to help you decide whether the stock looks attractive or stretched.
On Simply Wall St, Narratives sit inside the Community page and are designed so you can easily connect the story to a full financial forecast and a fair value. The system then updates that view automatically when fresh results, news or guidance come out.
For Axon Enterprise, one Narrative might lean toward the higher Fair Value of about US$925 per share because the author expects strong recurring software revenue, deep product entrenchment and a higher future P/E. Another might sit closer to the lower Fair Value of roughly US$521 per share because it focuses more on risks like sector multiple compression, regulation and reliance on government budgets. By comparing each Fair Value to the current price, you can see which story aligns better with your own expectations and risk tolerance.
Do you think there's more to the story for Axon Enterprise? Head over to our Community to see what others are saying!
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
